Lancet Psychiatry 5 , 739746 (2018)
Maes M, Crespo Yanguas S, Willebrords J, Weemhoff JL, da Silva TC, Decrock E, Lebofsky M, Pereira IVA, Leybaert L, Farhood A, Jaeschke H, Cogliati B, Vinken M
Although basal XOR expression is typically low in humans, various factors such as hypoxia, ischemia-reperfusion injury, interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and corticosteroid treatment can markedly enhance XOR transcription
Intravenous B12 Therapy Protocols Intravenous therapy is often chosen for quick fixes of vitamin B12 deficiency
After that, a single daily injection maintains relatively flat insulin coverage for 24 to 36 hours
However, when weight regain occurs despite these hormonal changes, pharmacological augmentation with GLP-1 receptor agonists may help restore the metabolic advantages